Thyroid Cancer Drugs are consumed to prevent the secretion and release of thyroid hormones from the thyroid glands

 

Thyroid Cancer Drugs

For those patients who do have thyroid disease and are candidates for surgery, radiation treatment or transplant, access to an effective thyroid medication can make all the difference in a positive outcome. There are other drugs in the works that may treat thyroid cancer and several of these have already undergone phase III clinical trials. One of these drugs is leupefin. Its manufacturer is Tosex Pharmaceuticals and it has already been approved in Canada for use in the treatment of lung cancer and renal cell carcinoma. In addition to treating patients with this disease, leupefin is also reported to be effective in treating breast cancer. It is being considered as an effective treatment for both stage I and stage II cancers.

In September 2021, the Indian biopharmaceutical company, BDR Pharma, launched Cabozantinib molecule, an inhibitor developed to improve accessibility of thyroid cancer drugs in the Asia Pacific region. Other new drugs being developed include trilastin and gemcitabine. Trilastin is being studied for use in the treatment of endometriosis, although its effect on tumors is less than desirable. Gemcitabine is undergoing phase III clinical trials and is being investigated for its ability to prevent and treat thyroid cancer. It has not yet received approval from the FDA for these purposes. One more newly developed drug, menthol, is also being tested for thyroid cancer treatment.

Since many of the existing drugs for treating hypothyroidism can have side effects that can cause damage to the liver or kidneys, researchers are constantly looking for other alternative ways of treating this condition. Although these conventional methods have worked well for some people, they still do not provide a full range of solutions. New alternatives to treating this disease may soon become available. Thyroid cancer drugs are only one of them.

Studies on how thyroid cancer drugs might affect one's health are few and still inconclusive. Research is also limited in terms of detecting toxicity at low doses. All of these factors combine to limit the effectiveness of vandetanib and its contemporaries. There is some speculation that future vandetanib may prove to be toxic, but until then, supply remains too low to meet demand.


Comments

Popular posts from this blog

Bell shaped pepper is a member of the Capsicum Baccatum species, which includes the Ají pepper

Light Linear Alpha Olefins Are Produces through Oligomerization of Ethylene and by Fischer-Tropsch Synthesis

How is Tissue Banking Beneficial to People with Severe Morbidity, Chronic Diseases, and Organ Transplant Surgery?